Browsing: over

A Florida teen ‌whose lawsuit claimed Meta’s platforms were to ​blame for his depression and anxiety ⁠dropped his case against the company just days before the trial in Los Angeles was ‌set to start, his attorneys said on Wednesday

Two pharmaceutical giants that dominate the global obesity drug market have clashed over advertising for their obesity treatments. Analysts say the fight to seize control of the rapidly growing obesity drug market, now worth hundreds of billions of dollars, has intensified. 

If you are a non-vegetarian, eating fish might have more benefits than eating meat and poultry in clinical obesity

Danish drugmaker Novo Nordisk has sued rival Eli Lilly, alleging the U.S. pharmaceutical giant is misleading consumers with ad campaigns that the company’s weight-loss and diabetes drugs are superior to Novo’s competing products, Reuters reported

There are plenty of ways to fall asleep, but some positions can affect your spine, back, and sleep quality

The Centers for Disease Control and Prevention has upped the number of cases of cyclosporiasis to more than 4,000 in 41 states

On Tuesday, Novo Nordisk initiated legal action against Eli Lilly, claiming the company’s promotional efforts for its popular obesity and diabetes medications intentionally deceive patients regarding their greater effectiveness compared to Novo’s competing products. The company objects to national advertisements that reference what it describes as obsolete study data, using those comparisons to pit the…

Health I went on a weight loss journey before going on a real journey. Adrian Kingsley-Hughes/ZDNET

Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by claiming Lilly’s drugs work better than Novo’s competing treatments

Danish pharmaceuticals heavyweight Novo Nordisk said Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and anti-diabetes treatments.